膀胱副神经节瘤1例

刘沛昆, 杨潇, 曹强, 等. 膀胱副神经节瘤1例[J]. 临床泌尿外科杂志, 2022, 37(11): 885-888. doi: 10.13201/j.issn.1001-1420.2022.11.018
引用本文: 刘沛昆, 杨潇, 曹强, 等. 膀胱副神经节瘤1例[J]. 临床泌尿外科杂志, 2022, 37(11): 885-888. doi: 10.13201/j.issn.1001-1420.2022.11.018
LIU Peikun, YANG Xiao, CAO Qiang, et al. Paraganglioma of urinary bladder: a case report[J]. J Clin Urol, 2022, 37(11): 885-888. doi: 10.13201/j.issn.1001-1420.2022.11.018
Citation: LIU Peikun, YANG Xiao, CAO Qiang, et al. Paraganglioma of urinary bladder: a case report[J]. J Clin Urol, 2022, 37(11): 885-888. doi: 10.13201/j.issn.1001-1420.2022.11.018

膀胱副神经节瘤1例

  • 基金项目:
    国家自然科学基金(No:82072832、82273152)
详细信息

Paraganglioma of urinary bladder: a case report

More Information
  • 膀胱副神经节瘤是一种罕见的肿瘤疾病,因多位于黏膜下层和肌层之间,且具有潜在恶性,故极易误诊为膀胱尿路上皮癌。本例报道1例27岁女性膀胱副神经节瘤患者。该患者因“大量血尿”入院,彩超、CT、MRI均提示膀胱占位。全身麻醉下行经尿道膀胱肿瘤电切手术,术后组织病理及免疫组织化学提示副神经节瘤。出院后2周再次发生无痛性肉眼血尿,全身麻醉下行膀胱部分切除术,术后痊愈出院。正确地诊断膀胱副神经节瘤具有重要的临床价值,尤其是影像学检查对诊断至关重要。手术是膀胱副神经节瘤最有效的治疗方法,而膀胱部分切除术是膀胱副神经节瘤的主要手术方式。
  • 加载中
  • 图 1  多参数MR

    图 2  彩超

    图 3  经尿道膀胱病损切除术后肿瘤病理镜检

    图 4  免疫组织化学

  • [1]

    黄健. 中国泌尿外科和男科疾病诊断治疗指南[M]. 科学出版社, 2020.

    [2]

    Williams P, Siref L, Feloney M. Pheochromocytoma of the urinary bladder[J]. N Engl J Med, 1953, 249(1): 25-26. doi: 10.1056/NEJM195307022490106

    [3]

    Yuan Y, Su Z, Zhu R, et al. Bladder paraganglioma: three cases report and literature review[J]. Int Med Case Rep J, 2021, 14: 765-771. doi: 10.2147/IMCRJ.S336659

    [4]

    汪群锋, 梁朝朝, 朱劲松, 等. 膀胱嗜铬细胞瘤1例诊治并文献复习[J]. 现代泌尿生殖肿瘤杂志, 2017, 9(5): 278-280. doi: 10.3870/j.issn.1674-4624.2017.05.007

    [5]

    Tu X, Zhang N, Zhuang X, et al. Incidental diagnosis of nonfunctional bladder paraganglioma: a case report and literature review[J]. BMC Urol, 2021, 21(1): 98. doi: 10.1186/s12894-021-00863-y

    [6]

    Priyadarshi V, Pal DK. Paraganglioma of urinary bladder[J]. Urol Ann, 2015, 7(3): 402-404. doi: 10.4103/0974-7796.152058

    [7]

    Wang S, Zhang A, Huang S, et al. Non functioning paraganglioma in the urinary bladder: a case report[J]. Urol J, 2020, 17(4): 426-428.

    [8]

    牛琳, 荣璐璐, 蒋涛. 膀胱副神经节瘤的多层螺旋CT诊断价值[J]. 实用放射学杂志, 2021, 37(6): 965-967, 988. https://www.cnki.com.cn/Article/CJFDTOTAL-XYXZ201410034.htm

    [9]

    Deng JH, Li HZ, Zhang YS, et al. Functional paragangliomas of the urinary bladder: a report of 9 cases[J]. Chin J Cancer, 2010, 29(8): 729-734. doi: 10.5732/cjc.009.10703

    [10]

    Quist EE, Javadzadeh BM, Johannesen E, et al. Malignant paraganglioma of the bladder: a case report and review of the literature[J]. Pathol Res Pract, 2015, 211(2): 183-188. doi: 10.1016/j.prp.2014.10.009

    [11]

    Frantellizzi V, Pontico M, Letizia C, et al. Bladder wall paraganglioma located using(123) I-mIBG SPECT and CT imaging[J]. Rev Esp Med Nucl Imagen Mol, 2018, 37(4): 253-254.

    [12]

    Degrieck B, De Visschere P, Lapauw B. Bladder Paraganglioma[J]. J Belg Soc Radiol, 2020, 104(1): 25. doi: 10.5334/jbsr.2064

    [13]

    Panebianco V, Narumi Y, Altun E, et al. Multiparametric magnetic resonance imaging for bladder cancer: development of Ⅵ-RADS(vesical imaging-reporting and data system)[J]. Eur Urol, 2018, 74(3): 294-306. doi: 10.1016/j.eururo.2018.04.029

    [14]

    范大铬, 吴春林, 黄海建, 等. 膀胱副神经节瘤23例临床病理学分析[J]. 中华病理学杂志, 2020, 49(4): 311-316. doi: 10.3760/cma.j.cn112151-20190928-00535

    [15]

    王乾, 任翠萍, 李莹, 等. 膀胱副神经节瘤一例[J]. 临床放射学杂志, 2017, 36(5): 662-663. doi: 10.13437/j.cnki.jcr.2017.05.016

    [16]

    Beilan JA, Lawton A, Hajdenberg J, et al. Pheochromocytoma of the urinary bladder: a systematic review of the contemporary literature[J]. BMC Urol, 2013, 13: 22. doi: 10.1186/1471-2490-13-22

    [17]

    Tsai CC, Wu WJ, Chueh KS, et al. Paraganglioma of the urinary bladder first presented by bladder bloody tamponade: two case reports and review of the literatures[J]. Kaohsiung J Med Sci, 2011, 27(3): 108-113. doi: 10.1016/j.kjms.2010.05.005

    [18]

    Das S, Bulusu NV, Lowe P. Primary vesical pheochromocytoma[J]. Urology, 1983, 21(1): 20-25. doi: 10.1016/0090-4295(83)90116-4

    [19]

    Ahn SG, Jang H, Han DS, et al. Transurethral resection of bladder tumour (TURBT) as an optional treatment method on pheochromocytoma of the urinary bladder[J]. Can Urol Assoc J, 2013, 7(1-2): E130-E134. doi: 10.5489/cuaj.255

    [20]

    Grossman A, Pacak K, Sawka A, et al. Biochemical diagnosis and localization of pheochromocytoma: can we reach a consensus?[J]. Ann N Y Acad Sci, 2006, 1073: 332-347. doi: 10.1196/annals.1353.038

    [21]

    金从军, 邵玉军, 曾正陪, 等. 131I-间位碘代苄胍治疗恶性嗜铬细胞瘤/副神经节瘤的临床疗效分析[J]. 中华泌尿外科杂志, 2015, 36(1): 24-28.

    [22]

    Kotecka-Blicharz A, Hasse-Lazar K, Handkiewicz-Junak D, et al. 131-I MIBG therapy of malignant pheochromocytoma and paraganglioma tumours-a single-centre study[J]. Endokrynol Pol, 2018, 69(3): 246-251. doi: 10.5603/EP.a2018.0024

    [23]

    You D, Ren R, Chen E, et al. Radiotherapy for urinary bladder pheochromocytoma with invasion of the prostate: A case report and literature review[J]. Mol Clin Oncol, 2016, 4(6): 1060-1062. doi: 10.3892/mco.2016.820

    [24]

    Sisson JC, Shapiro B, Shulkin BL, et al. Treatment of malignant pheochromocytomas with 131-I metaiodobenzylguanidine and chemotherapy[J]. Am J Clin Oncol, 1999, 22(4): 364-370. doi: 10.1097/00000421-199908000-00008

    [25]

    Joshua AM, Ezzat S, Asa SL, et al. Rationale and evidence for sunitinib in the treatment of malignant paraganglioma/pheochromocytoma[J]. J Clin Endocrinol Metab, 2009, 94(1): 5-9. doi: 10.1210/jc.2008-1836

    [26]

    Ilanchezhian M, Jha A, Pacak K, et al. Emerging treatments for advanced/metastatic pheochromocytoma and paraganglioma[J]. Curr Treat Options Oncol, 2020, 21(11): 85. doi: 10.1007/s11864-020-00787-z

    [27]

    Naing A, Meric-Bernstam F, Stephen B, et al. Phase 2 study of pembrolizumab in patients with advanced rare cancers[J]. J Immunother Cancer, 2020, 8(1): e000347.

  • 加载中

(4)

计量
  • 文章访问数:  600
  • PDF下载数:  115
  • 施引文献:  0
出版历程
收稿日期:  2021-11-08
刊出日期:  2022-11-06

目录